Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump inhibitor in original prescription formulation
Uploaded on May 15, 2009 / 19 views / 84 impressions / 0 comments
Description
Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump inhibitor in original prescription formulation.
Novartis announced today that Prevacid® 24HR (lansoprazole delayed-release capsules 15 mg) has...
Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump inhibitor in original prescription formulation.
Novartis announced today that Prevacid® 24HR (lansoprazole delayed-release capsules 15 mg) has been approved by the U.S. Food and Drug Administration (FDA) as the first over-the-counter (OTC) Proton Pump Inhibitor (PPI) for the treatment of frequent heartburn since 2003. Prevacid 24HR is expected to be available over-the-counter in 2009.
To view Multimedia News Release, go to http://www.prnewswire.com/mnr/prevacid/38457/
